| Pharmaceutical active ingredients: |
| HydrochlorothiazideIrbesartan |
| Available forms, composition and doses of CoAprovel: |
| Tablets, Film-Coated; Oral; Irbesartan 150 mg; Hydrochlorothiazide 12.5 mgTablets, Film-Coated; Oral; Irbesartan 300 mg; Hydrochlorothiazide 12.5 mgTablets, Film-Coated; Oral; Irbesartan 300 mg; Hydrochlorothiazide 25 mgTablets; Oral; Irbesartan 150 mg; Hydrochlorothiazide 25 mgTablets; Oral; Irbesartan 300 mg; Hydrochlorothiazide 12.5 mgTablets; Oral; Irbesartan 300 mg; Hydrochlorothiazide 25 mg |
| CoAprovel medical category: |
| Human:Angiotensin II receptor antagonistsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09DA04 - Irbesartan and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisBristol-Myers SquibbIDS GroupMetro Drug DistributionThe Glory MedicinaZuellig Pharma |
| Related documents and information about CoAprovel: |
| Coaprovel prescribing information (PDF) |